Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction.

已完结 10 由 rocenphone 发布于 2025/12/28 21:04:38

DOI:10.1056/EVIDoa2500268
作者：A W J Van't Hof,?C M Gibson,?S A O F Rikken,?J L Januzzi,?C B Granger,?A van Beurden,?S Rasoul,?L Ruiters,?J Vainer,?A Verburg,?F Arslan,?J W Jukema,?M Durieux,?J Polad,?R van Vliet,?B J L van den Bra
文献类型：期刊论文
补充材料：只需要正文

New England Journal of Medicine (NEJM)

Abstract：Background: Zalunfiban is a glycoprotein IIb/IIIa (integrin αIIbβ3) inhibitor designed for subcutaneous administration on first medical contact with patients with suspected ST-segment elevat

应助信息

4小时前

vwan

a73eb54de3ee11f09c4034735aa3bc31.pdf 已采纳

4小时前

Book学术机器人

2025/12/28 21:04:38 未找到该文献，机器人已退出，请等待人工下载

2025/12/28 21:04:38 Book学术AI机器人收到请求，开始寻找文献

2025/12/28 21:04:38 已向机器人发送请求

4小时前

rocenphone 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierOffshore wind energy in the Iberian Peninsula: A comparative analysis of availability, persistence, and complementarity with onshore wind and solar photovoltaic generation